Abstract
In this study, we analyze the amino acid pairs in human protein C precursor to determine which amino acid pairs are more susceptible to 71 variants from missense mutant human protein C precursor. The results show 85.92% of 71 variants occur at randomly unpredictable amino acid pairs accounting for 61.96% of amino acid pairs in protein C.
Keywords: protein c, probability, randomness, thrombophilia, variant, cycloamylose
Protein & Peptide Letters
Title: Amino Acid Pairs Susceptible to Variants in Human Protein C Precursor
Volume: 12 Issue: 5
Author(s): Guang Wu and Shaomin Yan
Affiliation:
Keywords: protein c, probability, randomness, thrombophilia, variant, cycloamylose
Abstract: In this study, we analyze the amino acid pairs in human protein C precursor to determine which amino acid pairs are more susceptible to 71 variants from missense mutant human protein C precursor. The results show 85.92% of 71 variants occur at randomly unpredictable amino acid pairs accounting for 61.96% of amino acid pairs in protein C.
Export Options
About this article
Cite this article as:
Wu Guang and Yan Shaomin, Amino Acid Pairs Susceptible to Variants in Human Protein C Precursor, Protein & Peptide Letters 2005; 12 (5) . https://dx.doi.org/10.2174/0929866054395248
DOI https://dx.doi.org/10.2174/0929866054395248 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Novel Oral Anticoagulants; “All that Glitters is not Gold, or is it?”)
Cardiovascular & Hematological Agents in Medicinal Chemistry Leptin: A Promising Therapeutic Target with Pleiotropic Action Besides Body Weight Regulation
Current Drug Targets From Proteins to Nucleic Acid-Based Drugs: The Role of Biotech in Anti-VEGF Therapy
Anti-Cancer Agents in Medicinal Chemistry Antiplatelet Therapy and Oral Anticoagulation for Prevention of Ischemic Stroke
Current Drug Therapy Cyano Acrylate Polymers in Medical Applications
Recent Patents on Materials Science Portable Technologies for Self-Monitoring of Coagulation Time: A Review
Current Biotechnology Novel Anticoagulants: New Evidence for Emerging Drugs and Their Potential Application in Major Lower Limb Surgery
Current Vascular Pharmacology Drug Therapies in the Secondary Prevention of Cardiovascular Diseases:Successes, Shortcomings and Future Directions
Current Vascular Pharmacology Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome
Current Drug Metabolism Thrombin Inhibitors and Anti-Factor Xa Agents in the Treatment of Arterial Occlusion
Current Drug Targets New Oral Anticoagulants and Their Reversal
Current Drug Safety Is the Carotid Plaque Rupture a Pivotal Event in Stroke Pathogenesis? Update on the Role of the Intraplaque Inflammatory Processes
Current Vascular Pharmacology Novel uses of Imaging in AF Ablation
Recent Patents on Cardiovascular Drug Discovery Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design Hemolysis-Associated Pulmonary Hypertension in Sickle Cell Disease: Global Disruption of the Arginine-Nitric Oxide Pathway
Current Hypertension Reviews Integrin Function and Signaling as Pharmacological Targets in Cardiovascular Diseases and in Cancer
Current Pharmaceutical Design Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets The Relationship Between HIV Infection and Cardiovascular Disease
Current Cardiology Reviews Gene Therapy for Cardiovascular Diseases
Current Pharmaceutical Design The Alteration of Coagulation in Patients with Thyroid Dysfunction
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)